You do not have uploaded videos yet.

Choose "Upload Response Video" option on left to create
new video and your response video as well.

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera

Medgenics Incorporated - symbol MDGN - reported that it has received notice of 'Intention to Grant' from the European Patent Office for the patent application entitled "USE OF DERMAL MICRO ORGANS,"...

Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera

Medgenics Incorporated - symbol MDGN - reported that it has received notice of 'Intention to Grant' from the European Patent Office for the patent application entitled "USE OF DERMAL MICRO ORGANS," with allowed claims covering a core element of its Biopump protein therapy technology.

This follows Similar U.S. Patent for Biopump Protein Therapy Technology and Expands Medgenics' Intellectual Property Portfolio.

Medgenics is developing and commercializing Biopump, a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own skin biopsy for the treatment of a range of chronic diseases including anemia, hepatitis C and hemophilia.

Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I'm Shalika Jayasekera

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.